MELBOURNE, Australia, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN) is pleased to advise our Chief Executive Officer, Steven Lydeamore presented early this morning at the ...
MELBOURNE, AUSTRALIA / ACCESSWIRE / November 18, 2024 / Immuron Limited (NASDAQ:IMRN) has one commercial product and two pipeline assets in three clinical programs for the treatment of gut mediated ...
Models: mouse, human cells. Åsa Sjöling studies how enterotoxigenic E. coli (ETEC) regulate virulence and survival in response to gastrointestinal- and environmental factors, and how antibiotic ...